Nataša Kovačević Grujičić, PhD, is a molecular biologist specializing in human molecular genetics and population genetics. She obtained her degree in Molecular Biology and Physiology in 1996, followed by a Master’s degree in 2000 at the Faculty of Biology, University of Belgrade. She completed her PhD at the same faculty in 2009, with a dissertation focused on the mechanisms of transcriptional regulation of the human SOX3 gene, one of the earliest neural markers in vertebrates. A significant part of her research has been dedicated to examining mitochondrial DNA variability in the population of Serbia and understanding the processes that shaped the modern mitochondrial gene pool of this population. In recent years, she has focused on studying the molecular mechanisms underlying the development of neurodevelopmental disorders, with the aim of developing new therapeutic approaches for their treatment. She has undertaken advanced training at Cardiff University and Maastricht University, where she gained expertise in reprogramming somatic cells into induced pluripotent stem cells (iPSCs), their neural differentiation, and transcriptome analysis. She coordinated work packages in several national projects and one international project (Horizon Europe – STREAMLINE), as well as a project within the Serbian Science and Diaspora Collaboration Program, which focused on the rare progeroid Mulvihill-Smith syndrome, identifying the causing mutations and developing new models for a better understanding of the molecular mechanisms underlying this condition.